We only use strictly necessary cookies (sign-in & payment) — no tracking. More in our Privacy Policy.
BAX · NYQ · Industrie & Produktion
22,21 $
+0.14 (+0.63 %) today
Last 4 completed fiscal years · Amounts in USD · SBC (stock-based compensation) & dividend per share · Growth YoY (prior year) · EPS as GAAP value (unadjusted; company-reported “adjusted” EPS may differ) · SBC & buyback shares are estimates (SBC shares ≈ expense ÷ current price)
| Fiscal year | Revenue | Net income | EPS (GAAP) | Shares (dil.) | SBC in shares | Buybacks (approx.) | Gross margin | Net margin | FCF / share | SBC / share | Dividend / share |
|---|---|---|---|---|---|---|---|---|---|---|---|
Last 8 quarters · Amounts in USD · Revenue, net income & EPS with growth YoY (year-ago quarter) and QoQ (prior quarter)
| Quarter | Revenue | Net income | EPS | Gross margin | Net margin | FCF / share |
|---|---|---|---|---|---|---|
| Q1 2026 | 2.7BYoY +2.9%QoQ -9.2% | -15MYoY -111.9% | -$0.03YoY -112% | 33 % | -0.6 % | — |
| Q4 2025 | 2.97B |
P/E
-11.9
EPS (GAAP)
-$1.87
FCF / share
$0.65
Market cap
11.47B USD
Revenue (TTM)
11.24B USD
Net margin
-8.5 %
Gross margin
30.1 %
Data source: SEC EDGAR / offizielle Geschäftsberichte · Prices may be delayed · Not investment advice
| 2025 |
|---|
| 11.24BYoY +5.7% |
| -957M |
| -$1.87 |
| 513M |
| 5.3 M · 1 % |
| 2.3 M · 0.4 % |
| 30.1 % |
| -8.5 % |
| $0.65 |
| $0.23 |
| $0.52 |
| 2024 | 10.64BYoY +2.7% | -649MYoY -124.4% | -$1.27YoY -124.3% | 510M | 5.1 M · 1 % | 3.1 M · 0.6 % | 37.5 % | -6.1 % | $1.12 | $0.22 | $1.04 |
|---|
| 2023 | 10.36BYoY +3% | 2.66B | $5.23 | 508M | 5.2 M · 1 % | 1.2 M · 0.2 % | 40.1 % | 25.6 % | $2.55 | $0.23 | $1.16 |
|---|
| 2022 | 10.06BYoY -17.2% | -2.43BYoY -289.5% | -$4.83YoY -290.9% | 504M | 6.3 M · 1.3 % | 10.3 M · 2 % | 35.3 % | -24.2 % | $1.65 | $0.28 | $1.15 |
|---|
| -1.13B |
| -$2.20 |
| 19.4 % |
| -37.9 % |
| — |
| Q3 2025 | 2.84BYoY +5%QoQ +0.9% | -46MYoY -132.9%QoQ -150.5% | -$0.09YoY -133.3%QoQ -150% | 33.5 % | -1.6 % | — |
|---|
| Q2 2025 | 2.81BYoY +4.3%QoQ +7% | 91MQoQ -27.8% | $0.18QoQ -28% | 35.3 % | 3.2 % | — |
|---|
| Q1 2025 | 2.63BQoQ -4.6% | 126M | $0.25 | 32.8 % | 4.8 % | — |
|---|
| Q4 2024 | 2.75BQoQ +2% | -512MQoQ -465.7% | -$1.00QoQ -470.4% | 34.8 % | -18.6 % | — |
|---|
| Q3 2024 | 2.7BQoQ +0.2% | 140M | $0.27 | 38.3 % | 5.2 % | — |
|---|
| Q2 2024 | 2.69B | -314M | -$0.61 | 38.3 % | -11.7 % | — |
|---|
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $19, Maintains Neutral Rating
MT Newswires · Jul 14, 2026
Sign in and try FairValue Pro free for 3 days — including the fair value of BAX and unlimited analyses.
Sign in & try 3 days freeThen €8.99/month · cancel anytime
Want to try first? The Alphabet valuation is free for everyone — no account.